NovaBay Pharmaceuticals NBY

$ 0.52 3.99%

Quarterly report 2024-Q3
added 11-07-2024

NovaBay Pharmaceuticals Total Liabilities 2011-2024 | NBY

Annual Total Liabilities NovaBay Pharmaceuticals

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
5.72 M	5.84 M	13.8 M	2.92 M	10.2 M	4.41 M	7.48 M	8.28 M	10.2 M	5.69 M	7.13 M	5.19 M	6.62 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
13.8 M	2.92 M	7.19 M

Quarterly Total Liabilities NovaBay Pharmaceuticals

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
2.8 M	4.54 M	5.2 M	5.72 M	5.82 M	7.44 M	5.94 M	5.84 M	8.59 M	5.8 M	7.05 M	13.8 M	2.88 M	2.39 M	3.09 M	2.92 M	2.92 M	2.92 M	2.92 M	10.2 M	10.2 M	10.2 M	10.2 M	4.41 M	4.41 M	4.41 M	4.41 M	7.48 M	7.48 M	7.48 M	7.48 M	8.28 M	8.28 M	8.28 M	8.28 M	10.2 M	10.2 M	10.2 M	6.01 M	5.69 M	5.69 M	5.69 M	5.69 M	7.13 M	7.13 M	7.13 M	7.13 M	5.19 M	5.19 M	5.19 M	5.19 M	6.62 M	6.62 M	6.62 M	6.62 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
13.8 M	2.39 M	6.46 M